Glycopeptide-based Compounds for Agricultural, Food, Environmental, and Medical Applications
Legal Citation
Summary of the Inventive Concept
The inventive concept leverages the core technology of lipo-glycopeptide cleavable derivatives to address various unmet needs in agricultural, food, environmental, and medical industries, providing novel solutions for disease prevention, food preservation, bioremediation, and medical device protection.
Background and Problem Solved
The original patent disclosed lipo-glycopeptide cleavable derivatives for treating Gram-positive bacterial infections. However, there is a growing need for innovative solutions in other industries, such as agriculture, food, environmental, and medical, to address pressing challenges like crop diseases, food spoilage, soil pollution, and medical device contamination. The new inventive concept addresses these limitations by applying the core technology to these new fields.
Detailed Description of the Inventive Concept
The inventive concept comprises glycopeptide-based compounds that are cleavable by enzymatic hydrolysis, which can be applied to various industries. In agriculture, the compounds can be used to detect and prevent crop diseases. In food preservation, the compounds inhibit bacterial and fungal growth, extending shelf life. In environmental remediation, the compounds break down pollutants in contaminated soil. In medical applications, the compounds treat bacterial diseases in aquatic life and prevent biofilm formation on medical devices. These compounds offer a versatile solution for diverse industries.
Novelty and Inventive Step
The new inventive concept introduces novel applications and use cases for the lipo-glycopeptide cleavable derivatives, which were not contemplated in the original patent. The inventive step lies in recognizing the potential of these compounds to address unmet needs in various industries, beyond their original purpose.
Alternative Embodiments and Variations
Alternative embodiments may include modifications to the glycopeptide-based compounds, such as varying the type of enzymatic hydrolysis or the specific industries in which they are applied. Variations may also include combining these compounds with other technologies, like nanotechnology or biotechnology, to enhance their effectiveness.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including agriculture, food processing, environmental remediation, and medical devices. The market size is substantial, with opportunities for partnerships, licensing, and product development.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/14 |
| A | A61 | A61K9/008 |
| A | A61 | A61K9/0073 |
| A | A61 | A61K9/0075 |
| A | A61 | A61P31/04 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and biotechnology research, specifically focused on antimicrobial compounds, drug delivery systems, and enzymatic treatments for bacterial infections across medical, agricultural, and environmental applications
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in microbiology, biochemistry, or pharmaceutical sciences, possessing expertise in compound design, enzymatic interactions, and interdisciplinary applications of antimicrobial technologies
Obviousness Rationale
A person of ordinary skill would recognize the inherent versatility of lipo-glycopeptide cleavable derivatives and find it obvious to extend their application beyond the original medical context to agricultural, environmental, and food preservation domains. The fundamental mechanism of enzymatic cleavage and antibacterial properties provides a predictable basis for exploring alternative use cases. The PTD represents a straightforward extrapolation of the source patent's core technological principles.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,597 |
|---|---|
| Title | Lipo-glycopeptide cleavable derivatives and uses thereof |
| Assignee(s) | Insmed Incorporated |